The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program

File(s)

The effects of canagliflozin on gout in type 2 diabetes a posthoc analysis of the CANVAS Program Lancet Rheum.pdf (616.69 KB)

Accepted version

Show more

Author(s)

Li, JingWei

Badve, Sunil V

Zhou, Zien

Rodgers, Anthony

Day, Richard

more

Type

Journal Article

Date Issued

2019-12-01

Date Acceptance

2019-11-11

Citation

The Lancet Rheumatology, 2019, 1 (4), pp.e220-e228

URI

http://hdl.handle.net/10044/1/79686

DOI

https://www.dx.doi.org/10.1016/s2665-9913(19)30078-5

ISSN

2665-9913

Publisher

Elsevier BV

Start Page

e220

End Page

e228

Journal / Book Title

The Lancet Rheumatology

Volume

1

Issue

4

Copyright Statement

© 2019 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/

Publication Status

Published

Date Publish Online

2019-11-26